Neuberger Berman Group LLC Intellia Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 128,898 shares of NTLA stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,898
Previous 171,362 24.78%
Holding current value
$1.5 Million
Previous $3.84 Million 30.95%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$19.72 - $27.36 $837,390 - $1.16 Million
-42,464 Reduced 24.78%
128,898 $2.65 Million
Q2 2024

Nov 14, 2024
BUY
$20.02 - $27.22 $752,251 - $1.02 Million
37,575 Added 28.09%
171,362 $3.84 Million
Q2 2024

Aug 13, 2024
BUY
$20.02 - $27.22 $752,251 - $1.02 Million
37,575 Added 28.09%
171,362 $3.84 Million
Q1 2024

Nov 14, 2024
SELL
$23.82 - $32.8 $44,067 - $60,679
-1,850 Reduced 1.36%
133,787 $3.68 Million
Q1 2024

May 13, 2024
BUY
$23.82 - $32.8 $3.19 Million - $4.39 Million
133,787 New
133,787 $3.68 Million
Q4 2023

Nov 14, 2024
SELL
$23.16 - $32.34 $827,391 - $1.16 Million
-35,725 Reduced 20.85%
135,637 $4.14 Million
Q4 2023

Feb 09, 2024
SELL
$23.16 - $32.34 $249,757 - $348,754
-10,784 Reduced 7.37%
135,637 $4.14 Million
Q3 2023

Nov 14, 2023
BUY
$31.62 - $45.78 $248,849 - $360,288
7,870 Added 5.68%
146,421 $4.63 Million
Q2 2023

Aug 11, 2023
BUY
$34.58 - $46.03 $1.17 Million - $1.55 Million
33,734 Added 32.18%
138,551 $5.65 Million
Q1 2023

May 12, 2023
SELL
$33.3 - $44.82 $117,648 - $158,349
-3,533 Reduced 3.26%
104,817 $3.91 Million
Q4 2022

Feb 13, 2023
SELL
$33.21 - $62.69 $1.04 Million - $1.96 Million
-31,325 Reduced 22.43%
108,350 $3.78 Million
Q3 2022

Nov 15, 2022
BUY
$53.92 - $71.7 $528,308 - $702,516
9,798 Added 7.54%
139,675 $7.84 Million
Q2 2022

Aug 15, 2022
BUY
$38.49 - $76.21 $737,776 - $1.46 Million
19,168 Added 17.31%
129,877 $6.74 Million
Q1 2022

May 13, 2022
SELL
$58.27 - $118.99 $699 - $1,427
-12 Reduced 0.01%
110,709 $8.06 Million
Q4 2021

Feb 11, 2022
BUY
$100.76 - $138.36 $493,320 - $677,410
4,896 Added 4.63%
110,721 $13.1 Million
Q3 2021

Nov 12, 2021
BUY
$132.37 - $176.78 $1.72 Million - $2.3 Million
12,998 Added 14.0%
105,825 $14.1 Million
Q2 2021

Aug 13, 2021
SELL
$60.88 - $161.91 $1.21 Million - $3.21 Million
-19,854 Reduced 17.62%
92,827 $15.1 Million
Q1 2021

May 13, 2021
BUY
$46.59 - $83.68 $1.51 Million - $2.71 Million
32,429 Added 40.41%
112,681 $9.06 Million
Q4 2020

Feb 10, 2021
BUY
$18.83 - $63.53 $335,776 - $1.13 Million
17,832 Added 28.57%
80,252 $4.38 Million
Q3 2020

Nov 12, 2020
BUY
$17.47 - $24.93 $111,545 - $159,178
6,385 Added 11.39%
62,420 $1.24 Million
Q2 2020

Aug 13, 2020
SELL
$11.14 - $22.87 $53,215 - $109,249
-4,777 Reduced 7.86%
56,035 $1.18 Million
Q1 2020

May 14, 2020
BUY
$9.44 - $15.58 $17,775 - $29,337
1,883 Added 3.2%
60,812 $743,000
Q4 2019

Feb 12, 2020
SELL
$10.43 - $17.67 $7,248 - $12,280
-695 Reduced 1.17%
58,929 $864,000
Q2 2019

Aug 13, 2019
BUY
$13.88 - $18.41 $78,630 - $104,292
5,665 Added 10.5%
59,624 $976,000
Q1 2019

May 13, 2019
BUY
$12.79 - $17.62 $96,564 - $133,031
7,550 Added 16.27%
53,959 $922,000
Q4 2018

Feb 12, 2019
SELL
$11.39 - $27.13 $307,313 - $731,994
-26,981 Reduced 36.76%
46,409 $633,000
Q3 2018

Nov 13, 2018
BUY
$25.78 - $32.6 $216,680 - $274,003
8,405 Added 12.93%
73,390 $2.1 Million
Q2 2018

Aug 13, 2018
SELL
$20.02 - $30.79 $24,424 - $37,563
-1,220 Reduced 1.84%
64,985 $1.78 Million
Q1 2018

May 08, 2018
BUY
$19.43 - $34.95 $14,086 - $25,338
725 Added 1.11%
66,205 $1.4 Million
Q4 2017

Feb 14, 2018
BUY
$17.39 - $31.12 $79,385 - $142,062
4,565 Added 7.49%
65,480 $1.26 Million
Q3 2017

Nov 15, 2017
BUY
$15.16 - $25.75 $923,471 - $1.57 Million
60,915
60,915 $1.51 Million

Others Institutions Holding NTLA

# of Institutions
313
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $886M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email